Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 43.00
+1.90 (4.62%)
Aug 26, 2026, 1:52 PM CST
Locus Cell Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19.4 | 12.74 | 2.36 | 0.41 | 0.6 | - | |
Revenue Growth | 274.71% | 440.66% | 480.30% | -32.33% | - | - |
Cost of Revenue | 6.57 | 6.46 | 0.69 | 0.24 | 0.1 | - |
Gross Profit | 12.82 | 6.27 | 1.67 | 0.17 | 0.5 | - |
Selling, General & Admin | 92.87 | 92.38 | 82.53 | 79.19 | 60.67 | 31.82 |
Research & Development | 85.93 | 88.47 | 77.51 | 61.41 | 31.97 | 1.7 |
Operating Expenses | 178.8 | 180.85 | 160.04 | 140.6 | 92.64 | 33.52 |
Operating Income | -165.98 | -174.58 | -158.37 | -140.43 | -92.14 | -33.52 |
Interest Expense | -2.3 | -2.09 | -1.2 | -1.28 | -1.32 | -1.09 |
Interest & Investment Income | 11.63 | 16.26 | 29.77 | 36.3 | 11.63 | 0.74 |
Currency Exchange Gain (Loss) | -21.37 | -21.37 | 16.45 | 6.36 | 27.62 | -0.64 |
Other Non Operating Income (Expenses) | 25.48 | 0.24 | 0.33 | 2.16 | 0.74 | - |
Pretax Income | -152.54 | -181.54 | -113.02 | -96.89 | -53.48 | -34.52 |
Net Income | -152.54 | -181.54 | -113.02 | -96.89 | -53.48 | -34.52 |
Net Income to Common | -152.54 | -181.54 | -113.02 | -96.89 | -53.48 | -34.52 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 201 | 200 | 200 | 200 | 200 | 127 |
Shares Outstanding (Diluted) | 201 | 200 | 200 | 200 | 200 | 127 |
Shares Change | 0.89% | 0.01% | - | - | 57.96% | 126512.00% |
EPS (Basic) | -0.76 | -0.91 | -0.57 | -0.48 | -0.27 | -0.27 |
EPS (Diluted) | -0.76 | -0.91 | -0.57 | -0.48 | -0.27 | -0.27 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -673.04 | -599.57 | -548.26 | -158.87 | -62.12 | -30.22 |
Free Cash Flow Per Share | -3.35 | -3.00 | -2.74 | -0.79 | -0.31 | -0.24 |
Gross Margin | 66.11% | 49.25% | 70.88% | 42.12% | 83.17% | - |
Operating Margin | -855.78% | -1370.51% | -6721.77% | -34588.18% | -15357.17% | - |
Profit Margin | -786.51% | -1425.20% | -4796.99% | -23865.52% | -8913.00% | - |
Free Cash Flow Margin | -3470.15% | -4706.97% | -23270.71% | -39131.53% | -10352.50% | - |
EBITDA | -147.35 | -158.94 | -149.21 | -136.48 | -91.25 | -33.36 |
D&A For EBITDA | 18.63 | 15.64 | 9.16 | 3.95 | 0.89 | 0.16 |
EBIT | -165.98 | -174.58 | -158.37 | -140.43 | -92.14 | -33.52 |